Invitae to buy VC-backed ArcherDX

Invitae has agreed to acquire Boulder, Colorado-based ArcherDX, a genomics analysis company, for $325 million.

22 June 2020•7 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare M&A Deals Briefs